Tumor Promotion in BRAF Wild-Type Tumors: In vitro experiments have demonstrated paradoxical activation of MAP-kinase signaling and increased cell proliferation in BRAF wild-type cells exposed to BRAF ...
Colorectal cancer is one of the most common types of tumor and is responsible for around 10% of cancer-related deaths worldwide. The tumor is particularly dangerous when it forms metastases—i.e.
Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, ...
In this video, Suneel Kamath, MD, discussed the approval of encorafenib (Braftovi, Array BioPharma) in combination with cetuximab (Erbitux, ImClone) and fluorouracil-based chemotherapy in metastatic ...
The EMA has backed new and expanded uses for multiple cancer drugs, signaling a push toward biomarker-driven, earlier-line ...
A randomized phase III trial of the impact of a structured exercise program on disease-free survival (DFS) in stage 3 or high-risk stage 2 colon cancer: Canadian Cancer Trials Group (CCTG) CO.21 ...
Please provide your email address to receive an email when new articles are posted on . Aspirin did not improve DFS for individuals with colorectal cancer liver metastases compared with placebo. OS ...
Phase 2 study to evaluate combination therapy in patients with metastatic colorectal cancer, targeting β-catenin-driven immune exclusion in liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results